Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity

Journal of Endocrinology

Volumn 185, Issue 1, 2005, Pages 35-44

  Vázquez, Patricia ^a   Roncero, Isabel ^a   Blázquez, Enrique ^a   Alvarez, Elvira ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALANINE; CYCLIC AMP; CYSTEINE; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; PALMITIC ACID; PROTEIN KINASE; PROTEIN KINASE C;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; WILD TYPE;

ADENYLATE CYCLASE; ALANINE; ANIMALS; CHO CELLS; CONSENSUS SEQUENCE; CRICETINAE; CYCLIC AMP; CYSTEINE; CYTOPLASM; ENDOCYTOSIS; FEMALE; GTP-BINDING PROTEINS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PALMITATES; PROTEIN KINASE C; RATS; RECEPTORS, GLUCAGON; SERINE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 17844387862     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06031     Document Type: Article

References (41)

1. Alvarez E, Girones N & Davis RJ 1990 Inhibition of the receptor-mediated endocytosis of diferric transferrin is associated with the covalent modification of the transferrin receptor with palmitic acid. Journal of Biological Chemistry 265 16644-16655.
2. Alvarez E, Roncero I, Chowen JA, Thorens B & Blázquez E 1996 Expression of the glucagon-like peptide-1 receptor gene in rat brain. Journal of Neurochemistry 66 920-927.
3. Barragán JM, Rodriguez R & Blázquez E 1994 Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1(7-36)amide in rats. American Journal of Physiology-Endocrinology and Metabolism 266 E459-E466.
4. Barragán JM, Rodríguez RE, Eng J & Blázquez E 1996 Interactions of exendin(9-39) with the effects of glucagon-like peptide-1(7-36)amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regulatory Peptides 67 63-68.
5. Benito E, Blázquez E & Bosch M 1998 Glucagon-like peptide-1(7-36)amide increases pulmonary surfactant secretion through a cyclic adenosine 3′,5′-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes. Endocrinology 139 2363-2368.
6. Bouvier M, Loisel TP & Hebert T 1995a Dynamic regulation of G-protein-coupled receptor palmitoylation: potential role in receptor function. Biochemical Society Transactions 23 577-581.
7. Bouvier M, Moffett S, Loisel TP, Mouillac B, Hebert T & Chidiac P 1995b Palmitoylation of G-protein-coupled receptor: a dynamic modification with functional consequences. Biochemical Society Transactions 23 116-120.
8. Calvo JC, Gisolfi CV, Blázquez E & Mora F 1995 Glucagon-like peptide-1(7-36)amide induces the release of aspartic acid and glutamine by the ventromedial hypothalamus of the conscious rat. Brain Research Bulletin 38 435-439.
9. 50) of an enzymatic reaction. Biochemical Pharmacology 22 3099-3108.
10. Chowen JA, Rodriguez de Fonseca F, Alvarez E, Navarro M, García-Segura LM & Blázquez E 1999 Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain. Neuropeptides 33 212-215.
11. Dillon JS, Tanizawa Y, Wheeler MB, Leng X-H, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA & Boyd AE III 1993 Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor. Endocrinology 133 1907
12. 2-adrenergic receptor. Nature 383 447-450.
13. Gutzwiller JP, Goke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, Winterhalder R, Conen D & Beglinger C 1999 Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 44 81-86.
14. Hawtin SR, Tobin AB, Patel S & Wheatley M 2001 Palmitoylation of vasopressin V1a receptor reveals different conformational requirements for signaling, agonist-induced receptor phosphorylation and sequestration. Journal of Biological Chemistry 276 38139-38146.
15. Heuser JE & Anderson RG 1989 Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. Journal of Cell Biology 108 389-400.
16. 1 dopamine receptor. Journal of Neurochemistry 65 1325-1331.
17. Jin SLC, Han VKM, Simmons JG, Towle AC, Lauder JM & Lund PK 1988 Distribution of glucagon-like peptide-1 (GLP-1), glucagon, and glycentin in the rat brain: an immunocytochemical study. Journal of Comparative Neurology 271 519-532.
18. Kreymann B, Williams G, Ghatei MA & Bloom SR 1987 Glucagon-like peptide-1(7-36): a physiological incretin in man. Lancet 2 1300-1304.
19. Kreymann B, Ghatei MA, Burnet P, Williams G, Kanse S, Diani AR & Bloom SR 1989 Characterization of glucagon-like peptide-1(7-36)amide in the hypothalamus. Brain Research 502 325-331.
20. 2-adrenergic receptor lacking the palmitoylated Cys 341. EMBO Journal 12 349-356.
21. 2-adrenergic receptor by the cAMP-dependent protein kinase. Journal of Biological Chemistry 271 21490-21497.
22. 2-adrenergic receptor regulates the synergistic action of cyclic AMP-dependent protein kinase and β-adrenergic receptor kinase involved in its phosphorylation and desensitization. Journal of Neurochemistry 76 269-279.
23. Mora F, Expósito I, Sanz B & Blázquez E 1992 Selective release of glutamine and glutamic acid produced by perfusion of GLP-1 (7-36)amide in the basal ganglia of the conscious rat. Brain Research Bulletin 29 359-361.
24. Morello JP & Bouvier M 1996 Palmitoylation: a post-translational modification that regulates signalling from G-protein-coupled receptor. Biochemistry and Cell Biology 74 449-457.
25. Navarro M, Rodriguez de Fonseca F, Alvarez E, Chowen JA, Zueco JA, Gómez R, Eng J & Blázquez E 1996 Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. Journal of Neurochemistry 67 1982-1991.
26. 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. Journal of Biological Chemistry 264 7564-7569.
27. Orskov C, Poulsen SS, Moller M & Holst JJ 1996 Glucagon-like peptide 1 receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide 1. Diabetes 45 832-835.
28. Palmer TM & Stiles GL 2000 Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Molecular Pharmacology 57 539-545.
29. Perry T, Lahiri DK, Chen D, Zhou J, Shaw KTY, Egan JM & Greig N 2002 A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. Journal of Phamacology and Experimental Therapeutics 300 958-966.
30. Rodriguez de Fonseca F, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gómez R, Muñoz RM, Eng J & Blázquez E 2000 Peripheral versus central effects of glucagon-like peptide-1 on satiety and body weight loss in Zucker obese rats. Metabolism 49 1-10.
31. Takhar S, Gyomorey S, Su R-C, Mathi SK, Li X & Wheeler MB 1996 The third cytoplasmic domain of the GLP-1 (7-36)amide receptor is required for coupling to the adenylyl cyclase system. Endocrinology 137 2175-2178.
32. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop D, Moller M & Sheikh SP 1996 Central administration of GLP-1(7-36)amide inhibits food and water intake in rats. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 271 R848-R856.
33. Thorens B 1992 Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. PNAS 89 8641-8645.
34. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CMB, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JPH, Smith DM, Ghatei MA, Herbert J & Bloom SR 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature] 379 69-72.
35. Vara E, Arias-Díaz J, García C, Balibrea JL, & Blázquez E 2001 Glucagon-like peptide-1(7-36)amide stimulates surfactant secretion in human type II pneumocytes. American Journal of Respiratory and Critical Care Medicine 163 840-846.
36. Wei Y & Mojsov S 1993 Tissue-specific expression of the human receptor for glucagon-like peptide-1: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Letters 358 219-224.
37. Weir GC, Mojsov S, Hendrich GK & Habener JF 1989 Glucagon-like peptide-1(7-37) actions on endocrine pancreas. Diabetes 38 338-342.
38. Wheeler MB, Lu M, Dillon JS, Leng X-H, Chen C & Boyd AE III 1993 Functional expression of the rat glucagon-like peptide-1 receptor, evidence for coupling to both adenylyl cyclase and phospholipase C. Endocrinology 133 57-62.
39. Widmann CH, Dolci W & Thorens B 1996a Heterologous desensitization of the glucagon-like peptide-1 receptor by phorbol esters requires phosphorylation of the cytoplasmic tail at four different sites. Journal of Biological Chemistry 271 19957-19963.
40. Widmann CH, Dolci W & Thorens B 1996b Desensitization and phosphorylation of the glucagon-like peptide-1 GLP-1 receptor by GLP-1 and 4-phorbol 12-myristate-13-acetate. Molecular Endocrinology 10 62-75.
41. Widmann CH, Dolci W & Thorens B 1997 Internalization and homologous desensitization of the GLP-1 receptor dependent on phosphorylation of the receptor carboxyl tail at the same three sites. Molecular Endocrinology 11 1094-1102.